An implant containing nanoparticles that can test for different substances and now being developed at MIT could one day help doctors rapidly monitor the growth of tumors and the progress of chemotherapy in cancer patients....

Roche Holding AG has unveiled a new method to track patients' responses to treatments by monitoring their genes. It detects active genes directly by using sensors attached to silicon cantilevers that are only 450 nanometers thick and therefore rea...